Answers are grounded in this paper and cite their sources.
Reveals PD-L1 expression and CD8<sup>+</sup> T cells as biomarkers for anti-PD-1 efficacy in melanoma, suggesting potential for better treatment outcomes.
T cells and PD-L1 expression in the tumors may be a biomarker for a good response to anti-PD-1 antibody monotherapy.
No takes yet. Share an insight, caveat, or question.
Manabe et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: